Voyager Therapeutics (VYGR) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $55.5 million.
- Voyager Therapeutics' Shares Outstanding rose 172.38% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 172.38%. This contributed to the annual value of $54.7 million for FY2024, which is 2428.11% up from last year.
- Per Voyager Therapeutics' latest filing, its Shares Outstanding stood at $55.5 million for Q3 2025, which was up 172.38% from $55.4 million recorded in Q2 2025.
- Voyager Therapeutics' Shares Outstanding's 5-year high stood at $55.5 million during Q3 2025, with a 5-year trough of $37.6 million in Q1 2021.
- Its 5-year average for Shares Outstanding is $45.5 million, with a median of $43.8 million in 2023.
- Its Shares Outstanding has fluctuated over the past 5 years, first soared by 139.3% in 2021, then skyrocketed by 2505.36% in 2024.
- Over the past 5 years, Voyager Therapeutics' Shares Outstanding (Quarter) stood at $37.9 million in 2021, then rose by 1.83% to $38.6 million in 2022, then rose by 14.05% to $44.0 million in 2023, then grew by 24.28% to $54.7 million in 2024, then increased by 1.37% to $55.5 million in 2025.
- Its last three reported values are $55.5 million in Q3 2025, $55.4 million for Q2 2025, and $55.2 million during Q1 2025.